Daphne Karydas
Director · 5 filings · Latest: Sep 15, 2026
COMPASS Pathways plc
Mineralys Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MLYS | Daphne Karydas | Director | Sep 15, 2026 | Sale | $28.58 | 3,000 | $85.7K | 6,200 | |
MLYS | Daphne Karydas | Director | Sep 15, 2026 | Option Exercise | $12.02 | 3,000 | $36.1K | 9,200 | |
MLYS | Karydas Daphne | — | Sep 15, 2026 | Proposed Sale | $28.58 | 3,000 | $85.7K | — | |
MLYS | Daphne Karydas | Director | Jun 17, 2026 | Sale | $25.00 | 3,000 | $75.0K | 6,200 | |
MLYS | Daphne Karydas | Director | Jun 17, 2026 | Option Exercise | $12.02 | 3,000 | $36.1K | 9,200 | |
MLYS | Karydas Daphne | — | Jun 17, 2026 | Proposed Sale | $25.00 | 3,000 | $75.0K | — | |
MLYS | Daphne Karydas | Director | Mar 31, 2026 | Sale | $25.00 | 3,000 | $75.0K | 6,200 | |
MLYS | Daphne Karydas | Director | Mar 31, 2026 | Option Exercise | $12.02 | 3,000 | $36.1K | 9,200 | |
MLYS | Karydas Daphne | — | Mar 31, 2026 | Proposed Sale | $25.00 | 3,000 | $75.0K | — | |
MLYS | Karydas Daphne | — | Nov 13, 2025 | Proposed Sale | $45.99 | 15,000 | $689.8K | — |